Qureight Appoints Patrick Driscoll as Chief Financial Officer
Starting 2025 on a high!
Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF
Qureight achieves ISO 27001 certification: gold standard for data security in healthcare
An Autumn Team Update From Qureight
Cancer Specialists Kent Yip & John Conibear are joining the Qureight, Scientific Advisory Board
Summer News and Updates From The Qureight Team
Qureight joins OSIC and gains access to world’s largest, curated data repository for ILDs
Qureight appoints Dr Steven Bishop as Chief Data Officer
Qureight appoints Dr Simon Walsh as Chief Scientific Officer
Qureight Partners with King Faisal Specialist Hospital and Research Centre for Innovative Lung Transplant Research Pilot
Appointment of Javier Alvarez Valle to Qureight Scientific Advisory Board
Claus Torp Jensen appointed as Chairperson of the Qureight Board
Qureight and Vicore Pharma release results characterising lung disease patients who may be more responsive to C21 treatment
Qureight collaborates with AstraZeneca on lung disease research
Dr Pilar Rivera-Ortega joins Qureight’s Scientific Advisory Board
Qureight is partnering with patientMpower to reveal AI insights for improved ILD care
